Search
for
Sort by
Research 151–180 of 1000+
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT
- Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study
- Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations
- Relationship between Serum Concentrations, Hemodynamic Effects, and Cardiovascular Lesions in Dogs Treated with Minoxidil
- Correction to ‘Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: A cross-sectional study’ [Journal of the American Academy of Dermatology 2026 July;95(1):104-111]
- THE IMPACT OF HOMOCYSTEINE IN LUPUS ERYTHEMATOSUS: A LINK OF INFLAMMATION, SKIN AND CARDIOVASCULAR RISK
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Lipid Profile, Atherogenic Index of Plasma, and Anthropometric Measurements Among Osteoporotic Postmenopausal Sudanese Women: Possible Risk for Cardiovascular Disease
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Scientific Opinion on the substantiation of health claims related to soy isoflavones and protection of DNA, proteins and lipids from oxidative damage (ID 1286, 4245), maintenance of normal blood LDL cholesterol concentrations (ID 1135, 1704a, 3093a), reduction of vasomotor symptoms associated with menopause (ID 1654, 1704b, 2140, 3093b, 3154, 3590), maintenance of normal skin tonicity (ID 1704a), contribution to normal hair growth (ID 1704a, 4254), “cardiovascular health” (ID 3587), treatment …
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Polycystic ovary syndrome
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
- The pathophysiology of polycystic ovary syndrome
- Hair cortisol analysis: An update on methodological considerations and clinical applications
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The diagnosis of polycystic ovary syndrome in adolescents